• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卫生规划和评价项目单元成本库:实践中的研究报告及经验教训

Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned.

机构信息

Avenir Health, Glastonbury, P.O. Box 1337, CT, 06033-6337, Glastonbury, USA.

Center for Health Decision Science, Harvard T.H. Chan School of Public Health, MA, Boston, USA.

出版信息

BMC Public Health. 2023 Jun 2;23(1):1055. doi: 10.1186/s12889-023-15964-6.

DOI:10.1186/s12889-023-15964-6
PMID:37264335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10234678/
Abstract

BACKGROUND

Most low- and middle-income countries have limited access to cost data that meets the needs of health policy-makers and researchers in health intervention areas including HIV, tuberculosis, and immunization. Unit cost repositories (UCRs)-searchable databases that systematically codify evidence from costing studies-have been developed to reduce the effort required to access and use existing costing information. These repositories serve as public resources and standard references, which can improve the consistency and quality of resource needs projections used for strategic planning and resource mobilization. UCRs also enable analysis of cost determinants and more informed imputation of missing cost data. This report examines our experiences developing and using seven UCRs (two global, five country-level) for cost projection and research purposes.

DISCUSSION

We identify advances, challenges, enablers, and lessons learned that might inform future work related to UCRs. Our lessons learned include: (1) UCRs do not replace the need for costing expertise; (2) tradeoffs are required between the degree of data complexity and the useability of the UCR; (3) streamlining data extraction makes populating the UCR with new data easier; (4) immediate reporting and planning needs often drive stakeholder interest in cost data; (5) developing and maintaining UCRs requires dedicated staff time; (6) matching decision-maker needs with appropriate cost data can be challenging; (7) UCRs must have data quality control systems; (8) data in UCRs can become obsolete; and (9) there is often a time lag between the identification of a cost and its inclusion in UCRs.

CONCLUSIONS

UCRs have the potential to be a valuable public good if kept up-to-date with active quality control and adequate support available to end-users. Global UCR collaboration networks and greater control by local stakeholders over global UCRs may increase active, sustained use of global repositories and yield higher quality results for strategic planning and resource mobilization.

摘要

背景

大多数中低收入国家获取成本数据的渠道有限,而这些数据是卫生政策制定者和研究人员在艾滋病毒、结核病和免疫等卫生干预领域开展工作所必需的。单位成本存储库(UCR)是一种可搜索的数据库,它对成本研究中的证据进行了系统的编码,可以减少获取和使用现有成本信息所需的工作量。这些存储库是公共资源和标准参考,可以提高战略规划和资源调动中资源需求预测的一致性和质量。UCR 还可以分析成本决定因素,并更准确地推断缺失的成本数据。本报告考察了我们为成本预测和研究目的开发和使用七个 UCR(两个全球、五个国家层面)的经验。

讨论

我们确定了在开发和使用 UCR 方面的进展、挑战、推动因素和经验教训,这些经验教训可能为未来与 UCR 相关的工作提供信息。我们的经验教训包括:(1)UCR 并不能替代成本核算专业知识的需求;(2)需要在数据复杂性程度和 UCR 的可用性之间进行权衡;(3)简化数据提取使向 UCR 中添加新数据变得更容易;(4)决策者的即时报告和规划需求通常会推动利益相关者对成本数据的兴趣;(5)开发和维护 UCR 需要专门的员工时间;(6)使决策者的需求与适当的成本数据相匹配可能具有挑战性;(7)UCR 必须有数据质量控制系统;(8)UCR 中的数据可能会过时;(9)成本数据通常需要一定的时间才能被纳入 UCR。

结论

如果 UCR 保持最新状态并为最终用户提供积极的质量控制和足够的支持,它们有可能成为有价值的公共产品。全球 UCR 协作网络以及当地利益相关者对全球 UCR 的更大控制,可能会增加对全球存储库的积极、持续使用,并为战略规划和资源调动提供更高质量的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9af/10236574/d6cb43f68da0/12889_2023_15964_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9af/10236574/d6cb43f68da0/12889_2023_15964_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9af/10236574/d6cb43f68da0/12889_2023_15964_Fig1_HTML.jpg

相似文献

1
Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned.卫生规划和评价项目单元成本库:实践中的研究报告及经验教训
BMC Public Health. 2023 Jun 2;23(1):1055. doi: 10.1186/s12889-023-15964-6.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Tuberculosis结核病
5
Counting the cost of not costing HIV health facilities accurately: pay now, or pay more later.未能准确核算艾滋病毒防治设施成本的代价:现在就付出,还是以后付出更多。
Pharmacoeconomics. 2012 Oct 1;30(10):887-902. doi: 10.2165/11596500-000000000-00000.
6
Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners.估算撒哈拉以南非洲扩大艾滋病毒/艾滋病和结核病干预措施的资源需求:面向国家政策制定者和规划者的系统评价
Health Policy. 2006 Nov;79(1):1-15. doi: 10.1016/j.healthpol.2005.11.005. Epub 2006 Jan 4.
7
Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).常规免疫的成本与筹资:多国研究(EPIC)的方法与部分研究结果
Vaccine. 2015 May 7;33 Suppl 1:A13-20. doi: 10.1016/j.vaccine.2014.12.066.
8
Health economics in developing countries.发展中国家的卫生经济学
J Trop Med Hyg. 1989 Aug;92(4):229-41.
9
Lessons learned from Evidence-Informed Decision-Making in Nutrition & Health (EVIDENT) in Africa: a project evaluation.从非洲营养与健康循证决策(EVIDENT)中学到的经验教训:项目评估。
Health Res Policy Syst. 2019 Jan 31;17(1):12. doi: 10.1186/s12961-019-0413-6.
10
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.

本文引用的文献

1
Moving away from the "unit cost". Predicting country-specific average cost curves of VMMC services accounting for variations in service delivery platforms in sub-Saharan Africa.脱离“单位成本”。预测撒哈拉以南非洲国家特定的 VMMC 服务平均成本曲线,考虑服务提供平台的差异。
PLoS One. 2021 Apr 22;16(4):e0249076. doi: 10.1371/journal.pone.0249076. eCollection 2021.
2
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression.中低收入国家结核病治疗费用:系统评价和荟萃回归分析。
Int J Tuberc Lung Dis. 2020 Aug 1;24(8):802-810. doi: 10.5588/ijtld.19.0694.
3
Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates.
制定标准化国家免疫接种单位成本估算。
Pharmacoeconomics. 2020 Sep;38(9):995-1005. doi: 10.1007/s40273-020-00930-6.
4
A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries.一种使用来自非洲国家的汇总机构层面原始数据来估计抗逆转录病毒治疗平均单位成本的荟萃分析方法。
Afr J AIDS Res. 2019 Dec;18(4):297-305. doi: 10.2989/16085906.2019.1688362.
5
Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: methodology and lessons learned.开发全球卫生成本联盟艾滋病毒和结核病单位成本研究知识库:方法与经验教训。
Afr J AIDS Res. 2019 Dec;18(4):263-276. doi: 10.2989/16085906.2019.1680398.
6
An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.2004年至2012年发展中国家儿科抗逆转录病毒药物市场的销量、价格及定价趋势分析。
BMC Pediatr. 2016 Mar 15;16:41. doi: 10.1186/s12887-016-0578-x.
7
Cost drivers for voluntary medical male circumcision using primary source data from sub-Saharan Africa.利用撒哈拉以南非洲的原始数据探究男性自愿医学包皮环切术的成本驱动因素。
PLoS One. 2014 May 6;9(5):e84701. doi: 10.1371/journal.pone.0084701. eCollection 2014.
8
Towards an improved investment approach for an effective response to HIV/AIDS.迈向改进艾滋病投资方法,以有效应对艾滋病。
Lancet. 2011 Jun 11;377(9782):2031-41. doi: 10.1016/S0140-6736(11)60702-2.
9
Factors influencing global antiretroviral procurement prices.影响全球抗逆转录病毒药物采购价格的因素。
BMC Public Health. 2009 Nov 18;9 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2458-9-S1-S6.
10
Resource requirements to fight HIV/AIDS in Latin America and the Caribbean.拉丁美洲和加勒比地区抗击艾滋病毒/艾滋病所需的资源。
AIDS. 2002 Dec;16 Suppl 3:S58-65. doi: 10.1097/00002030-200212003-00009.